SEEG-Guided DBS for OCD

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 13, 2023

Primary Completion Date

March 1, 2026

Study Completion Date

January 1, 2027

Conditions
Obsessive-Compulsive Disorder
Interventions
DEVICE

PMT Stereoencephalography (SEEG)

For Stage 1 of this study, we will be implanting depth electrodes to record stereoencephalography across a network of brain regions.

DEVICE

Vercise Genus™ Deep Brain Stimulation (DBS) System

For Stages 2 and 3 of this study, we intend to use the DBS system to treat patients with severe symptoms of chronic, treatment-refractory OCD by targeting stimulation to sites that have been determined to have therapeutic benefit during our SEEG Invasive Monitoring phase.

Trial Locations (2)

19106

RECRUITING

University of Pennsylvania, Philadelphia

94304

NOT_YET_RECRUITING

Stanford University, Stanford

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Casey H. Halpern, M.D.

OTHER